Home › Therapeutic areas › Renal › Lupus Nephritis
Lupus Nephritis (6 companies)
Companies with an active program in Lupus Nephritis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | HematologyOphthalmologyRenalRespiratory Rare | 1 | Approved | 14 |
| ANNX | Annexon, Inc. | HematologyNeurologyOphthalmologyRenal Rare | 1 | NDA Submitted | 6 |
| ARTV | Artiva Biotherapeutics, Inc. | DermatologyImmunologyOncologyRenal Rare | 1 | Phase 2 | 16 |
| CABA | Cabaletta Bio, Inc. | DermatologyImmunologyNeurologyRenal Rare | 1 | Phase 1 | 8 |
| IPSC | Century Therapeutics, Inc. | ImmunologyMetabolicRenal Rare | 2 | Phase 1 | 11 |
| KYTX | Kyverna Therapeutics, Inc. | ImmunologyNeurologyRenal Rare | 1 | NDA Submitted | 7 |
No companies match.